These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Stop TB Partnership has provided treatments for 10 million people in 6 years. Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093 [No Abstract] [Full Text] [Related]
44. [Clinical aspects and therapy of tuberculosis]. Höffken G; Deppermann KM Internist (Berl); 1995 Oct; 36(10):961-9. PubMed ID: 7499072 [No Abstract] [Full Text] [Related]
45. New UK guidance on the prevention and control of transmission of HIV related and drug resistant tuberculosis. Commun Dis Rep CDR Wkly; 1999 Feb; 9(6):49. PubMed ID: 10024752 [No Abstract] [Full Text] [Related]
46. [Epidemiology of multi-drug resistant tuberculosis in AIDS]. Moro ML Recenti Prog Med; 1999 Oct; 90(10):515-21. PubMed ID: 10592736 [No Abstract] [Full Text] [Related]
47. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era? Ollé-Goig JE Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741 [No Abstract] [Full Text] [Related]
48. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?]. Valencia ME; Moreno V; Laguna F; González-Lahoz JM Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251 [No Abstract] [Full Text] [Related]
49. Multi drug resistant tuberculosis: what will happen in developing countries? Colebunders R; Dujardin B; Taelman H; Portaels F Ann Soc Belg Med Trop; 1994 Dec; 74(4):263-7. PubMed ID: 7726660 [No Abstract] [Full Text] [Related]
51. The worldwide epidemic of multidrug-resistant tuberculosis. The Lancet Infectious Diseases Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885 [No Abstract] [Full Text] [Related]
52. [Tuberculosis--still a problem?]. Magnussen H Fortschr Med; 1995 Mar; 113(9):1. PubMed ID: 7759040 [No Abstract] [Full Text] [Related]
53. Epidemiology of tuberculosis: the impact of HIV and multidrug-resistant strains. Crawford JT Immunobiology; 1994 Oct; 191(4-5):337-43. PubMed ID: 7713547 [TBL] [Abstract][Full Text] [Related]
54. Emergence of multiple-drug-resistant tuberculosis: fundamental and applied research aspects, global issues and current strategies. Rastogi N Res Microbiol; 1993 Feb; 144(2):103. PubMed ID: 8337466 [No Abstract] [Full Text] [Related]
55. Essential components of a tuberculosis control program within Australia. National Tuberculosis Advisory Committee Commun Dis Intell Q Rep; 2014 Dec; 38(4):E397-400. PubMed ID: 25631607 [No Abstract] [Full Text] [Related]
56. Case records of the Massachusetts General Hospital. Case 18-2009. A 24-year-old woman with AIDS and tuberculosis with progressive cough, dyspnea, and wasting. Wilson D; Hurtado RM; Digumarthy S N Engl J Med; 2009 Jun; 360(23):2456-64. PubMed ID: 19494222 [No Abstract] [Full Text] [Related]
58. Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation. Migliori GB; Lienhardt C; Weyer K; van der Werf MJ; Blasi F; Raviglione MC Eur Respir J; 2014 Dec; 44(6):1412-7. PubMed ID: 25435528 [No Abstract] [Full Text] [Related]
59. [Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection]. Mishin VIu; Vasil'eva IA; Martynova LP Probl Tuberk; 1999; (6):20-2. PubMed ID: 10715950 [No Abstract] [Full Text] [Related]
60. [Extremely resistant tuberculosis in Africa. The Danish Society for Tropical Medicine and International Health]. Ravn P; Vestergaard LS; David KP; Ugeskr Laeger; 2007 Mar; 169(12):1135. PubMed ID: 17394846 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]